UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Update on the diagnosis and management of gestational trophoblastic disease

International journal of gynecology and obstetrics, 2018-10, Vol.143 (S2), p.79-85

2018

Volltextzugriff (PDF)

Second Curettage for Low-Risk Nonmetastatic Gestational Trophoblastic Neoplasia

Obstetrics and gynecology (New York. 1953), 2016-09, Vol.128 (3), p.535-542

2016

Volltextzugriff (PDF)

Avelumab in Patients With Gestational Trophoblastic Tumors With Resistance to Single-Agent Chemotherapy: Cohort A of the TROPHIMMUN Phase II Trial

Journal of clinical oncology, 2020-09, Vol.38 (27), p.3129-3137

2020

Volltextzugriff (PDF)

Differential diagnosis of non-molar gestational trophoblastic neoplasia with ectopic pregnancy by clinical–pathological features

Archives of gynecology and obstetrics, 2024-10, Vol.310 (4), p.2161-2166

2024

Volltextzugriff (PDF)

Does hormonal contraception during molar pregnancy follow-up influence the risk and clinical aggressiveness of gestational trophoblastic neoplasia after controlling for risk factors?

Gynecologic oncology, 2017-11, Vol.147 (2), p.364-370

2017

Volltextzugriff (PDF)

Risk factors for second‐line dactinomycin failure after methotrexate treatment for low‐risk gestational trophoblastic neoplasia: a retrospective study

BJOG : an international journal of obstetrics and gynaecology, 2020-08, Vol.127 (9), p.1139-1145

2020

Volltextzugriff (PDF)

The added value of hysterectomy in the management of gestational trophoblastic neoplasia

Gynecologic oncology, 2017-06, Vol.145 (3), p.536-542

2017

Volltextzugriff (PDF)

Early prediction of post-molar gestational trophoblastic neoplasia and resistance to methotrexate, based on a single serum human chorionic gonadotropin measurement

Gynecologic oncology, 2021-12, Vol.163 (3), p.531-537

2021

Volltextzugriff (PDF)

Risk adapted single-agent dactinomycin or carboplatin for second-line treatment of methotrexate resistant low-risk gestational trophoblastic neoplasia

Gynecologic oncology, 2016-12, Vol.143 (3), p.565-570

2016

Volltextzugriff (PDF)

Uterine arteriovenous malformations following gestational trophoblastic neoplasia: a systematic review

European journal of obstetrics & gynecology and reproductive biology, 2014-10, Vol.181, p.54-59

2014

Volltextzugriff (PDF)

Presence of the methylenetetrahydrofolate reductase gene polymorphism MTHFR C677T in molar tissue but not maternal blood predicts failure of methotrexate treatment for low-risk gestational trophoblastic neoplasia

European journal of pharmacology, 2017-01, Vol.794, p.85-91

2017

Volltextzugriff (PDF)

Predictive factors of relapse in low-risk gestational trophoblastic neoplasia patients successfully treated with methotrexate alone

American journal of obstetrics and gynecology, 2016-07, Vol.215 (1), p.80.e1-80.e7

2016

Volltextzugriff (PDF)

Can Pretreatment Serum Beta-hCG be Used for Predicting Thyrotoxicosis in Gestational Trophoblastic Disease?

Asian Pacific Journal of Cancer Prevention, 2021-11, Vol.22 (11), p.3461-3465

2021

Volltextzugriff (PDF)

Placental site trophoblastic tumour: the rarest subtype of gestational trophoblastic disease

BMJ case reports, 2020-10, Vol.13 (10), p.e235756

2020

Volltextzugriff (PDF)

Prognostic factors associated with time to hCG remission in patients with low-risk postmolar gestational trophoblastic neoplasia

Gynecologic oncology, 2013-08, Vol.130 (2), p.312-316

2013

Volltextzugriff (PDF)

Relapse rates after two versus three consolidation courses of methotrexate in the treatment of low-risk gestational trophoblastic neoplasia

Gynecologic oncology, 2012-06, Vol.125 (3), p.576-579

2012

Volltextzugriff (PDF)

Gestational Trophoblastic Disease Diagnosis Delayed by the Hook Effect

Obstetrics and gynecology (New York. 1953), 2015-10, Vol.126 (4), p.811-814

2015

Volltextzugriff (PDF)

Serum angiogenesis profile in gestational trophoblastic neoplasm using multiplex immunoassay

Life sciences (1973), 2018-10, Vol.211, p.25-30

2018

Volltextzugriff (PDF)

Incidence and outcome of gestational trophoblastic disease in lower Egypt

African health sciences, 2020-03, Vol.20 (1), p.73-82

2020

Volltextzugriff (PDF)

Postmolar gestational trophoblastic neoplasia: beyond the traditional risk factors

Fertility and sterility, 2015-09, Vol.104 (3), p.649-654

2015

Volltextzugriff (PDF)

Prognosis of Patients with Gestational Trophoblastic Neoplasia and Obstetric Outcomes of Those Conceiving After Chemotherapy

Anticancer research, 2016-07, Vol.36 (7), p.3477-3482

2016

Volltextzugriff (PDF)

Risk of gestational trophoblastic neoplasia after hCG normalisation according to hydatidiform mole type

Gynecologic oncology, 2013-07, Vol.130 (1), p.86-89

2013

Volltextzugriff (PDF)

Follow-up of gestational trophoblastic disease/neoplasia via quantification of circulating nucleic acids of placental origin using C19MC microRNAs, hypermethylated RASSF1A, and SRY sequences

Tumor biology, 2017-04, Vol.39 (4), p.1010428317697548-1010428317697548

2017

Volltextzugriff (PDF)

A retrospective study to evaluate single agent methotrexate treatment in low risk gestational choriocarcinoma in the United Kingdom

Gynecologic oncology, 2015-02, Vol.136 (2), p.258-263

2015

Volltextzugriff (PDF)

Long-term outcome of patients with persistent low-level elevation of human chorionic gonadotrophin

The journal of obstetrics and gynaecology research, 2016-06, Vol.42 (6), p.694-700

2016

Volltextzugriff (PDF)

1 – 25 von 249

Suche als RSS-Feed

Aktive Filter

ThemaAdult

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(229)
Mit Volltextzugriff
(167)

Publikationsform

Artikel
(249)

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Update on the diagnosis and management of gestational trophoblastic disease

Second Curettage for Low-Risk Nonmetastatic Gestational Trophoblastic Neoplasia

Avelumab in Patients With Gestational Trophoblastic Tumors With Resistance to Single-Agent Chemotherapy: Cohort A of the TROPHIMMUN Phase II Trial

Differential diagnosis of non-molar gestational trophoblastic neoplasia with ectopic pregnancy by clinical–pathological features

Does hormonal contraception during molar pregnancy follow-up influence the risk and clinical aggressiveness of gestational trophoblastic neoplasia after controlling for risk factors?

Risk factors for second‐line dactinomycin failure after methotrexate treatment for low‐risk gestational trophoblastic neoplasia: a retrospective study

The added value of hysterectomy in the management of gestational trophoblastic neoplasia

Early prediction of post-molar gestational trophoblastic neoplasia and resistance to methotrexate, based on a single serum human chorionic gonadotropin measurement

Risk adapted single-agent dactinomycin or carboplatin for second-line treatment of methotrexate resistant low-risk gestational trophoblastic neoplasia

Uterine arteriovenous malformations following gestational trophoblastic neoplasia: a systematic review

Presence of the methylenetetrahydrofolate reductase gene polymorphism MTHFR C677T in molar tissue but not maternal blood predicts failure of methotrexate treatment for low-risk gestational trophoblastic neoplasia

Predictive factors of relapse in low-risk gestational trophoblastic neoplasia patients successfully treated with methotrexate alone

Can Pretreatment Serum Beta-hCG be Used for Predicting Thyrotoxicosis in Gestational Trophoblastic Disease?

Placental site trophoblastic tumour: the rarest subtype of gestational trophoblastic disease

Prognostic factors associated with time to hCG remission in patients with low-risk postmolar gestational trophoblastic neoplasia

Relapse rates after two versus three consolidation courses of methotrexate in the treatment of low-risk gestational trophoblastic neoplasia

Gestational Trophoblastic Disease Diagnosis Delayed by the Hook Effect

Serum angiogenesis profile in gestational trophoblastic neoplasm using multiplex immunoassay

Incidence and outcome of gestational trophoblastic disease in lower Egypt

Postmolar gestational trophoblastic neoplasia: beyond the traditional risk factors

Prognosis of Patients with Gestational Trophoblastic Neoplasia and Obstetric Outcomes of Those Conceiving After Chemotherapy

Risk of gestational trophoblastic neoplasia after hCG normalisation according to hydatidiform mole type

Follow-up of gestational trophoblastic disease/neoplasia via quantification of circulating nucleic acids of placental origin using C19MC microRNAs, hypermethylated RASSF1A, and SRY sequences

A retrospective study to evaluate single agent methotrexate treatment in low risk gestational choriocarcinoma in the United Kingdom

Long-term outcome of patients with persistent low-level elevation of human chorionic gonadotrophin

Aktive Filter

Suchergebnisse filtern